BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25283145)

  • 1. The FHIT gene product: tumor suppressor and genome "caretaker".
    Waters CE; Saldivar JC; Hosseini SA; Huebner K
    Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
    Saldivar JC; Park D
    Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
    Karras JR; Schrock MS; Batar B; Huebner K
    Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
    Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
    PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication stress induces tumor-like microdeletions in FHIT/FRA3B.
    Durkin SG; Ragland RL; Arlt MF; Mulle JG; Warren ST; Glover TW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):246-51. PubMed ID: 18162546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
    Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
    PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic instability of the tumor suppressor gene FHIT in normal human cells.
    Palumbo E; Tosoni E; Matricardi L; Russo A
    Genes Chromosomes Cancer; 2013 Sep; 52(9):832-44. PubMed ID: 23780737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit loss-associated initiation and progression of neoplasia in vitro.
    Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
    Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
    Pecherzewska R; Nawrot B
    Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Fhit-ing role in the DNA damage checkpoint response.
    Ishii H; Wang Y; Huebner K
    Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fhit tumor suppressor: guardian of the preneoplastic genome.
    Pichiorri F; Palumbo T; Suh SS; Okamura H; Trapasso F; Ishii H; Huebner K; Croce CM
    Future Oncol; 2008 Dec; 4(6):815-24. PubMed ID: 19086848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do FHIT gene alterations play a role in human solid tumors?
    Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile gene product, Fhit, in oxidative and replicative stress responses.
    Okumura H; Ishii H; Pichiorri F; Croce CM; Mori M; Huebner K
    Cancer Sci; 2009 Jul; 100(7):1145-50. PubMed ID: 19486340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and biology associated with the fragile FHIT gene and gene product.
    Saldivar JC; Shibata H; Huebner K
    J Cell Biochem; 2010 Apr; 109(5):858-65. PubMed ID: 20082323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
    Zanesi N; Pekarsky Y; Croce CM
    Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
    Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
    Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.